Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.

Ref: NEPHROPLUS/SE/077 August 13, 2026 To To BSE Limited Na(cid:415)onal Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Lis(cid:415)ng Centre Through: NEAPS Subject: In(cid:415)ma(cid:415)on of Schedule of Analyst / Ins(cid:415)tu(cid:415)onal Investor mee(cid:415)ngs under the Securi(cid:415)es and Exchange Board of India (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements), Regula(cid:415)ons, 2015 (“SEBI Lis(cid:415)ng Regula(cid:415)ons”) Dear Sir/ Madam, Pursuant to Regula(cid:415)on 30(6) read with Schedule III of the SEBI Lis(cid:415)ng Regula(cid:415)ons, as amended from (cid:415)me to (cid:415)me, we would like to inform you that the officials of the Company will be a(cid:425)ending an Investor Conference as per the details below: Date & Time Conference Nature of Mee(cid:415)ng Place 18th August, 2026 Grand Hya(cid:425), 11:00 AM IST MOSL Conference Group / 1*1 Mee(cid:415)ng Mumbai Onwards Discussions will be based on publicly available informa(cid:415)on. No unpublished price sensi(cid:415)ve informa(cid:415)on (UPSI) is intended to be discussed during the interac(cid:415)ons. Kindly note that changes may happen due to exigencies on the part of Host / Company. The above disclosure is available on the website of the Company www.nephroplus.com Yours sincerely, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895